Picture of Maat Pharma SA logo

MAAT — Maat Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: MaaT Pharma Q1 Revenue At EUR 0.7 Million

May 9 (Reuters) - Maat Pharma SA  MAAT.PA :
    * MAAT PHARMA ANNOUNCES CASH AND REVENUES FOR Q1 OF 2023
    * AS OF MARCH 31, 2023, CASH AND CASH EQUIVALENTS WERE EUR
40.7
MILLION
    * REVENUES OF EUR 0.7 MILLION IN Q1 2023
    * SIGNIFICANT GROWTH REFLECTS INCREASING DEMAND, OVER
PERIOD, FOR
USE OF MAAT013 UNDER EARLY ACCESS PROGRAM IN EUROPE

Source text for Eikon:  ID:nBw6rl84ra 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Maat Pharma SA

See all news